IC
CNMD icon

Innealta Capital’s CONMED CNMD Stock Holding History

Innealta Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-595
Closed -$41.2K – 464
2024
Q2 		$41.2K Buy
+595
New +$43.4K 0.01% 413

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Innealta Capital's CNMD Position: Q3 2024 in Review

Innealta Capital sold out of CONMED (CNMD) in Q3 2024, closing a stake of 595 shares — an estimated $41.2K sold.

Innealta Capital first reported a position in CNMD in Q2 2024 and held it in 1 quarter. The position peaked at $41.2K in Q2 2024. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

  • Innealta Capital reported no remaining CONMED position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 595 CONMED shares in Q3 2024, an estimated $41.2K.
  • Innealta Capital first reported a position in CONMED in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's CONMED position peaked at $41.2K in Q2 2024.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.